AbbVie halts enrollment after brain cancer trial misses goal, shares fall
The trial has been testing the drug, Depatux-M, to treat an aggressive form of brain cancer known as glioblastoma
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Thermo Fisher Scientific inaugurates new facility in Ahmedabad
The state-of-the art facility in the domestic tariff area (DTA) is part of Thermo Fisher’s clinical trials business and was built…
WuXi STA and Dizal sign CMC Development and Manufacturing Agreement
WuXi STA will now provide Dizal integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services…
Torrent Pharma posts Q4 net loss of Rs 152 cr
Also, for the fiscal year ended March 2019, the company posted a net profit of Rs 436 crore as against Rs 678 crore for the…
Glenmark gets US FDA nod for Solifenacin Succinate Tablets
The US FDA approved the Abbreviated New Drug Application for Solifenacin Succinate Tablets, which are a generic version of…
GlaxoSmithKline reports an eight per cent revenue growth for FY19
The company recently released its consolidated financial results, wherein it reported a 21 per cent hike in net revenue for FY19
Dr Reddy’s to spend up to USD 300 mn on R&D in FY 2019
The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the…
AstraZeneca moves US court against Aurobindo Pharma on generic
The AstraZeneca alleged that the Indian drug makers proposed generic Daliresp would infringe the patents on three counts and…
TAKE Solution announces consolidated financial results
The company reported a 28.5 per cent growth in revenues at Rs 20,390 mn and a growth of 11.6 per cent in net profits for FY19;…
Jubilant Life Sciences announces consolidated financial results for Q4 & 12M’FY19 Results
The company reported a 21 per cent hike in YoY total revenue at Rs. 9,111 Crore